Analysis of the potential effect of ponatinib on the QTc interval in patients with refractory hematological malignancies

PURPOSE: Cardiac dysfunction, particularly QT interval prolongation, has been observed with tyrosine kinase inhibitors approved to treat chronic myeloid leukemia. This study examines the effects of ponatinib on cardiac repolarization in patients with refractory hematological malignancies enrolled in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Sonnichsen, Daryl, Dorer, David J., Cortes, Jorge, Talpaz, Moshe, Deininger, Michael W., Shah, Neil P., Kantarjian, Hagop M., Bixby, Dale, Mauro, Michael J., Flinn, Ian W., Litwin, Jeffrey, Turner, Christopher D., Haluska, Frank G.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer-Verlag 2013
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3668123/
https://ncbi.nlm.nih.gov/pubmed/23609479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2160-7
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak